Evidence map›Paper›PMID 32943636›Full record

ArticleNature communications2020

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.

Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, Kristina Iribarren, Juliette Humeau, Jonathan G Pol, Sarah Levesque, Laura Mondragon, Takahiro Yamazaki, Ai Sato and 20 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Aitziber BuquéDepartment of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.ORCID http://orcid.org/0000-0002-7698-8778
Norma BloyDepartment of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
Maria Perez-LanzónEquipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France.
Kristina IribarrenEquipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France.
Juliette HumeauEquipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France.
Jonathan G PolEquipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France.
Sarah LevesqueEquipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France.
Laura MondragonEquipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France.
Takahiro YamazakiDepartment of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.ORCID http://orcid.org/0000-0002-7420-4394
Ai SatoDepartment of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.ORCID http://orcid.org/0000-0002-5408-2596
Fernando ArandaEquipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France.ORCID http://orcid.org/0000-0002-9364-474X
Sylvère DurandEquipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France.
Alexandre BoissonnasSorbonne Université, Inserm, CNRS, Centre d'Immunologie et des Maladies Infectieuses CIMI, Paris, France.
Jitka FucikovaSotio, Prague, Czech Republic.
Laura SenovillaEquipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France.
David EnotEquipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France.
Michal HenslerSotio, Prague, Czech Republic.
Margerie KremerEquipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France.
Gautier StollEquipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France.ORCID http://orcid.org/0000-0002-0862-4139
Yang HuCaryl and Israel Englander Institute for Precision Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-6348-874X
Chiara MassaInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Silvia C FormentiDepartment of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.ORCID http://orcid.org/0000-0002-8227-8924
Barbara SeligerInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Olivier ElementoCaryl and Israel Englander Institute for Precision Medicine, New York, NY, USA.
Radek SpisekSotio, Prague, Czech Republic.
Fabrice AndréGustave Roussy Cancer Center, Villejuif, France.ORCID http://orcid.org/0000-0001-5795-8357
Laurence ZitvogelFaculté de Médecine, Université de Paris Sud, Paris-Saclay, Le Kremlin-Bicêtre, Paris, France.
Suzette DelalogeDepartment of Cancer Medicine, Gustave Roussy Cancer Center, Villejuif, France.ORCID http://orcid.org/0000-0003-2106-9165
Guido KroemerEquipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France. kroemer@orange.fr.ORCID http://orcid.org/0000-0002-9334-4405
Lorenzo GalluzziDepartment of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. deadoc80@gmail.com.ORCID http://orcid.org/0000-0003-2257-8500

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32943636
PMCPMC7499156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.